The global humanized mouse model market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for animal-free research models in various fields such as oncology, immunology and infectious diseases, neuroscience, toxicology and hematopoiesis. The increasing number of clinical trials in these fields is also driving the growth of this market.
The genetic humanized mouse models segment accounted for the largest share in 2018 owing to its high accuracy and reliability as compared with other types of humanized mouse models. This segment is expected to maintain its dominance throughout the forecast period due to its high accuracy and reliability as compared with other types of humanized mouse models.
Oncology accounted for the largest share in 2018 owing to an increase in cancer cases globally which has led researchers towards developing new drugs that are more effective against cancer cells than traditional chemotherapy drugs or radiation therapy treatments. Immunology & Infectious Diseases was another major application segment accounting for a significant share due to increased incidence rates among people across different age groups worldwide which has led researchers towards developing new vaccines that are more effective against infectious diseases than traditional vaccines or antibiotics treatments.
Some Of The Growth Factors Of This Market:
- The Humanized Mouse Model market is driven by the increasing prevalence of chronic diseases, such as diabetes and obesity, which are major risk factors for cardiovascular diseases and cancer.
- Increasing awareness about the benefits of using humanized mouse models in research will drive the growth of this market.
- Increasing number of collaborations between academia and industry will drive the growth of this market.
Industry Growth Insights published a new data on “Humanized Mouse Model Market”. The research report is titled “Humanized Mouse Model Market research by Types (Genetic Humanized Mouse Models, Cell-based Humanized Mouse Models), By Applications (Oncology, Immunology and Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, Others), By Players/Companies genOway, Horizon Discovery, Taconic Biosciences, Jackson Laboratory, AXENSIS, Champion Oncology, Crown Bioscience, HuMurine Technologies, InGenious Targeting Laboratory, TRANS GENIC, Harbour Biomed”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Humanized Mouse Model Market Research Report
By Type
Genetic Humanized Mouse Models, Cell-based Humanized Mouse Models
By Application
Oncology, Immunology and Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, Others
By Companies
genOway, Horizon Discovery, Taconic Biosciences, Jackson Laboratory, AXENSIS, Champion Oncology, Crown Bioscience, HuMurine Technologies, InGenious Targeting Laboratory, TRANS GENIC, Harbour Biomed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Humanized Mouse Model Market Report Segments:
The global Humanized Mouse Model market is segmented on the basis of:
Types
Genetic Humanized Mouse Models, Cell-based Humanized Mouse Models
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Immunology and Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- genOway
- Horizon Discovery
- Taconic Biosciences
- Jackson Laboratory
- AXENSIS
- Champion Oncology
- Crown Bioscience
- HuMurine Technologies
- InGenious Targeting Laboratory
- TRANS GENIC
- Harbour Biomed
Highlights of The Humanized Mouse Model Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Genetic Humanized Mouse Models
- Cell-based Humanized Mouse Models
- By Application:
- Oncology
- Immunology and Infectious Diseases
- Neuroscience
- Toxicology
- Hematopoiesis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Humanized Mouse Model Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A humanized mouse model is a mouse model that has been modified to have more similar features to humans. This can be done by adding human genes into the mouse's genome, or by surgically altering the mice so that they more closely resemble humans in their anatomy and physiology.
Some of the key players operating in the humanized mouse model market are genOway, Horizon Discovery, Taconic Biosciences, Jackson Laboratory, AXENSIS, Champion Oncology, Crown Bioscience, HuMurine Technologies, InGenious Targeting Laboratory, TRANS GENIC, Harbour Biomed.
The humanized mouse model market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Humanized Mouse Model Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Humanized Mouse Model Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Humanized Mouse Model Market - Supply Chain
4.5. Global Humanized Mouse Model Market Forecast
4.5.1. Humanized Mouse Model Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Humanized Mouse Model Market Size (000 Units) and Y-o-Y Growth
4.5.3. Humanized Mouse Model Market Absolute $ Opportunity
5. Global Humanized Mouse Model Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Humanized Mouse Model Market Size and Volume Forecast by Type
5.3.1. Genetic Humanized Mouse Models
5.3.2. Cell-based Humanized Mouse Models
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Humanized Mouse Model Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Humanized Mouse Model Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Immunology and Infectious Diseases
6.3.3. Neuroscience
6.3.4. Toxicology
6.3.5. Hematopoiesis
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Humanized Mouse Model Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Humanized Mouse Model Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Humanized Mouse Model Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Humanized Mouse Model Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Humanized Mouse Model Demand Share Forecast, 2019-2026
9. North America Humanized Mouse Model Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Humanized Mouse Model Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Humanized Mouse Model Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Immunology and Infectious Diseases
9.4.3. Neuroscience
9.4.4. Toxicology
9.4.5. Hematopoiesis
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Humanized Mouse Model Market Size and Volume Forecast by Type
9.7.1. Genetic Humanized Mouse Models
9.7.2. Cell-based Humanized Mouse Models
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Humanized Mouse Model Demand Share Forecast, 2019-2026
10. Latin America Humanized Mouse Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Humanized Mouse Model Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Humanized Mouse Model Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Immunology and Infectious Diseases
10.4.3. Neuroscience
10.4.4. Toxicology
10.4.5. Hematopoiesis
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Humanized Mouse Model Market Size and Volume Forecast by Type
10.7.1. Genetic Humanized Mouse Models
10.7.2. Cell-based Humanized Mouse Models
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Humanized Mouse Model Demand Share Forecast, 2019-2026
11. Europe Humanized Mouse Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Humanized Mouse Model Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Humanized Mouse Model Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Immunology and Infectious Diseases
11.4.3. Neuroscience
11.4.4. Toxicology
11.4.5. Hematopoiesis
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Humanized Mouse Model Market Size and Volume Forecast by Type
11.7.1. Genetic Humanized Mouse Models
11.7.2. Cell-based Humanized Mouse odels
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Humanized Mouse Model Demand Share, 2019-2026
12. Asia Pacific Humanized Mouse Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Humanized Mouse Model Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Humanized Mouse Model Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Immunology and Infectious Diseases
12.4.3. Neuroscience
12.4.4. Toxicology
12.4.5. Hematopoiesis
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Humanized Mouse Model Market Size and Volume Forecast by Type
12.7.1. Genetic Humanized Mouse Models
12.7.2. Cell-based Humanized Mouse Models
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Humanized Mouse Model Demand Share, 2019-2026
13. Middle East & Africa Humanized Mouse Model Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Humanized Mouse Model Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Humanized Mouse Model Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Immunology and Infectious Diseases
13.4.3. Neuroscience
13.4.4. Toxicology
13.4.5. Hematopoiesis
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Humanized Mouse Model Market Size and Volume Forecast by Type
13.7.1. Genetic Humanized Mouse Models
13.7.2. Cell-based Humanized Mouse Models
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Humanized Mouse Model Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Humanized Mouse Model Market: Market Share Analysis
14.2. Humanized Mouse Model Distributors and Customers
14.3. Humanized Mouse Model Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. genOway
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Horizon Discovery
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Taconic Biosciences
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jackson Laboratory
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AXENSIS
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Champion Oncology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Crown Bioscience
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. HuMurine Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. InGenious Targeting Laboratory
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. TRANS GENIC
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Harbour Biomed
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
